All News

CURE spoke with advocate Karen Hoyt about liver cancer, liver disease, and liver health, highlighting silent risk, misconceptions and need for awareness.

Dr. Benjamin Jon Golas outlines pancreatic cancer care, including surgery, chemotherapy, radiation and emerging targeted therapies at specialized centers.

Patient education and individualized navigation can improve genomic testing uptake and downstream participation in genomics-based clinical trials.

A patient with bladder cancer and CLL reflects on how the Japanese art of Ikebana taught acceptance, presence and self-compassion while living with cancer.

A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death.

The FDA accepted a new drug application for gedatolisib for patients with HR+, HER2-, PIK3CA wild-type advanced breast cancer.

In patients with high-risk melanoma, intismeran autogene and Keytruda reduced the risk of recurrence or death compared to Keytruda alone.

An expert explains how a DLL3 blood test may help guide Imdelltra use and set expectations for patients with small cell lung cancer.

For Richard “Rocky” Kimball, a diagnosis of myelodysplastic syndromes, or MDS, necessitated a number of lifestyle changes.

I have lived with both depression and cancer and know that illness, visible or not, ebbs and flows; canceled plans can reflect health limits, not rejection

CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials.

The FDA granted orphan drug designation to LP-284 for soft tissue sarcomas, supporting development of the investigational therapy for patients with cancer.

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful contributions to others’ lives.

There’s no moral to my story, except to say I’m grateful for good doctors and modern medicine.

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal cancer care.

CURE sat down with Dr. Surbhi Sidana to discuss this treatment combination.

I reflect on cancer and faith, embracing the power of one to pursue health, purpose, and positive change in my life and for others.

Patients with advanced gastric cancer received PD-1 inhibitors at similar rates across racial groups, although overall use remained limited in real-world care.

Patients with relapsed/refractory diffuse large B-cell lymphoma who received Epkinly alone experienced an improvement in progression-free survival.

Oya Gilbert, diagnosed with myeloma in 2017, uses advocacy and music to improve awareness, access and support for patients with cancer.

A chronic myeloid leukemia diagnosis can be daunting, but its management is one of modern oncology’s greatest success stories.

Learn about advanced treatments for stage 4 papillary thyroid cancer, such as radioiodine and targeted therapy, mapping the disease and managing side effects to empower your journey.

This guide is designed to provide you with a clear medical foundation so you can engage in informed, collaborative discussions with your oncology team.

Learn about large cell lung cancer, from diagnosis to stage-specific treatments, side effects and care options to guide patients through their journey.

My name is Beth Kramer, and I am 58 years old. Over the past 15 years, I have faced the life-altering words, “you have cancer,” not once, but three times.

At Keck Medicine of USC, surgeons, oncologists and radiation specialists collaborate closely, ensuring individualized care for patients with lung cancer.

CURE sat down with Dr. Surbhi Sidana to discuss this treatment combination and what its approval by the FDA would mean for patients.

Two people have transformed my journey from pain into possibility. In their presence, I find the strength to continue. Together, they've taught me that even in collapse and ill health, life can bloom again.